重组人B7-H7/HHLA2(His标签)|Recombinant Human B7-H7/HHLA2(93569ES)
产品应用
B7-H7, also known as HHLA2 (HERV-H LTR-associating 2), is a member of the B7 family of immune regulatory proteins. Mature human B7-H7 consists of a 322 amino acid (aa) extracellular domain (ECD) with three immunoglobulin-like domains, a 21 aa transmembrane segment, and a 49 aa cytoplasmic domain. B7H7 is constitutively expressed on monocytes and is up-regulated by LPS and IFN-gamma stimulation. It is expressed on LPS/IFN-gamma treated B cells but not on resting B cells. B7-H7 binds to cell surface determinants on resting and mature T cells, B cells, and monocytes as well as on immature and mature dendritic cells. Soluble B7-H7 inhibits the proliferation of activated CD4+ and CD8+ T cells and their production of IFN-gamma, TNF-alpha, IL-5, IL-10, IL-13, IL-17A, and IL-22.
高纯度、高活性、低内毒素、高批间一致性
Tris-Bis PAGE

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
310
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
334
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
356
2026-08-31
【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台
548
2026-06-25
【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”
847
2026-04-29
【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?
661
2026-04-29
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
1309
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
983
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
817
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
878
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
1202
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
1102
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1739
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14874
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11484
2026-09-21





